Skip to main content
SpringerLink
Log in

Dietary Approach to NAFLD

  • Chapter
  • First Online:
Non-Alcoholic Fatty Liver Disease

  • 759 Accesses

Abstract

Background: Healthy diet could promote control of the progression of nonalcoholic fatty liver disease (NAFLD). Weight loss, metabolic control, and hepatic protection could be three main ways to avoid disease progression. Methods: Systematic Review of manuscripts published addressing diet and NAFLD. Results: Macronutrients such as saturated fatty acids (SFA), trans-fats, simple sugars, and animal proteins have a harmful effect on the liver. Monounsaturated fats (MUFAs), polyunsaturated (PUFAs) omega-3-fats, plant-based proteins, and dietary fibers are considered to be beneficial to the liver. The impact of specific micronutrients is less well-known. Nutrients are part of the food we eat. Food makes up our meals, which compose our dietary patterns. Nonalcoholic fatty liver disease patients usually follow Western diets which are rich in soda, frozen junk food, juice, red meat, lard, processed meats, whole fat dairy foods, fatty snack foods, take-away foods, cakes, and biscuits and poor in cereals, whole grains, fruit, vegetables, extra virgin olive oil (EVOO), and fish. The Mediterranean diet (MD) is the top beneficial diet for NAFLD even when it is isocaloric or there are no changes in body weight because it protected from liver disease and controlled metabolic derangement. Nutritional geometry allowed us to integrate on a balanced model nutrition, humans, and environment. Conclusions: The goal of this approach is to combine nutrients and foods in a model to understand how food components interact to regulate the properties of diets affecting health and NAFLD.

Authors declare no conflict of interest.

No financial support received for this task.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67:829–46.

    Article  PubMed  Google Scholar 

  2. Bellentani S. The epidemiology of non-alcoholic fatty liver disease. Liver Int. 2017;37:81–4.

    Article  PubMed  Google Scholar 

  3. Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577–86.

    Article  PubMed  Google Scholar 

  4. Ampuero J, Romero-Gómez M. Influence of non-alcoholic fatty liver disease on cardiovascular disease. Gastroenterol Hepatol. 2012;35(8):585–93.

    Article  PubMed  Google Scholar 

  5. Ampuero J, Gallego-Durán R, Romero-Gómez M. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. Rev Esp Enfermedades Dig. 2015;107(1):10–6.

    Google Scholar 

  6. Musso G, Cassader M, Cohney S, et al. Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities. Diabetes Care. 2016;39(10):1830–45.

    Article  CAS  PubMed  Google Scholar 

  7. Kim G-A, Lee HC, Choe J, et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2018;68(1):140–6.

    Article  Google Scholar 

  8. LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, et al. World gastroenterology organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol. 2014;48:467–73.

    Article  PubMed  Google Scholar 

  9. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, Fagà E, Silli B, Pagano G. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003;37:909–16.

    Article  CAS  PubMed  Google Scholar 

  10. Asrih M, Jornayvaz FR. Diets and nonalcoholic fatty liver disease: the good and the bad. Clin Nutr. 2014;33:186–90.

    Article  PubMed  Google Scholar 

  11. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology (Baltimore, Md). 2010;51(1):121–9.

    Article  CAS  Google Scholar 

  12. Sofi F, Casini A. Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner? World J Gastroenterol. 2014;20:7339–46.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Aller R, Izaola O, De la Fuente B, De Luis Roman DA. Mediterranean diet is associated with liver histology in patients with non alcoholic fatty liver disease. Nutricion Hospitalaria. 2015;32:2518–24.

    PubMed  Google Scholar 

  14. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr. 2004;23:447–56.

    Article  CAS  PubMed  Google Scholar 

  15. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nälsén C, Berglund L, Louheranta A, Rasmussen BM, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia. 2001;44:312–9.

    Article  CAS  PubMed  Google Scholar 

  16. Clark SJ, Shojaee-Moradie F, Croos P, Seed PT, Umpleby AM, Wendon JA, Miell J. Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen. Hepatology. 2001;34:109–15. [PMID: 11431740].

    Article  CAS  PubMed  Google Scholar 

  17. Serrano-Martinez M, Palacios M, Martinez-Losa E, Lezaun R, Maravi C, Prado M, Martínez JA, Martinez-Gonzalez MA. A Mediterranean dietary style influences TNF-alpha and VCAM-1 coronary blood levels in unstable angina patients. Eur J Nutr. 2005;44:348–54.

    Article  CAS  PubMed  Google Scholar 

  18. Madigan C, Ryan M, Owens D, Collins P, Tomkin GH. Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care. 2000;23:1472–7.

    Article  CAS  PubMed  Google Scholar 

  19. Cooper R, Morré DJ, Morré DM. Medicinal benefits of green tea: part I. Review of noncancer health benefits. J Altern Complement Med. 2005;11:521–8.

    Article  PubMed  Google Scholar 

  20. Sarkhy AA, Al-Hussaini AA, Nobili V. Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis. Saudi J Gastroenterol. 2014;20:143–53.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Porikos KP, Van Itallie TB. Diet-induced changes in serum transaminase and triglyceride levels in healthy adult men. Role of sucrose and excess calories. Am J Med. 1983;75:624–30.

    Article  CAS  PubMed  Google Scholar 

  22. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48:993–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lê KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89:1760–5.

    Article  PubMed  CAS  Google Scholar 

  24. Jebb SA, Lovegrove JA, Griffin BA, Frost GS, Moore CS, Chatfield MD, Bluck LJ, Williams CM, Sanders TAB, on behalf of the RISCK Study Group. Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr. 2010;92:748–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Chung M, Ma J, Patel K, Berger S, Lau J, Lichtenstein AH. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100:833–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, Camilo ME. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr. 2006;25(5):816–23.

    Article  CAS  PubMed  Google Scholar 

  27. Cheng Y, Zhang K, Chen Y, Li Y, Li Y, Fu K, Feng R. Associations between dietary nutrient intakes and hepatic lipid contents in NAFLD patients quantified by 1H-MRS and dual-Echo MRI. Nutrients. 2016;8(9):527.

    Article  PubMed Central  CAS  Google Scholar 

  28. Shen H, Rodriguez AC, Shiani A, Lipka S, Shahzad G, Kumar A, et al. Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis. Ther Adv Gastroenterol. 2016;9(1):113–20.

    Article  CAS  Google Scholar 

  29. Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Ünalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR, Nonalcoholic Steatohepatitis Clinical Research Network. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305(16):1659–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming groth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther. 2001;15(10):1667–72.

    Article  CAS  PubMed  Google Scholar 

  31. Chalasani NP, Sanyal AJ, Kowdley KV, Robuck PR, Hoofnagle J, Kleiner DE, Unalp A, Tonascia J. Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with nonalcoholic steatohepatitis: PIVENS trial design. Contemp Clin Trials. 2009;30:88–96.

    Article  CAS  PubMed  Google Scholar 

  32. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. JAMA. 2007;297:842–57.

    Article  CAS  PubMed  Google Scholar 

  33. Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, Koteish AA, Clark JM, Guallar E, Hernaez R. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38(3):246–54.

    Article  CAS  PubMed  Google Scholar 

  34. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, Arcaro G. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517–24.

    Article  CAS  PubMed  Google Scholar 

  35. Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol. 2013;19(40):6911–8.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Eslamparast T, Eghtesad S, Poustchi H, Hekmatdoost A. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. World J Hepatol. 2015;7(2):204–12.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Fields M, Holbrook J, Scholfield D, Smith JC Jr, Reiser S. Effect of fructose or starch on copper-67 absorption and excretion by the rat. J Nutr. 1986;116:625–32.

    Article  CAS  PubMed  Google Scholar 

  38. Yang Z, Yan C, Liu G, Niu Y, Zhang W, Lu S, Li X, Zhang H, Ning G, Fan J, Qin L, Su Q. Plasma selenium levels and nonalcoholic fatty liver disease in Chinese adults: a cross-sectional analysis. Sci Rep. 2016;6:37288.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kaur HD, Bansal MP. Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation. Lipids Health Dis. 2009;8:55.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case control study. Am J Gastroenterol. 2007;102:1251–8.

    Article  CAS  PubMed  Google Scholar 

  41. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Investig. 2009;119:1322–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Aguirre L, Puy Portillo M, Hijona E, Bujanda L. Effects of resveratrol and other polyphenols in hepatic steatosis. World J Gastroenterol. 2014;20(23):7366–80.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Sato K, Arai H, Mizuno A, Fukaya M, Sato T, Koganei M, Sasaki H, Yamamoto H, Taketani Y, Doi T, Takeda E. Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats. J Nutr. 2007;137:1908–15.

    Article  CAS  PubMed  Google Scholar 

  44. Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146(6):1513–24.

    Article  CAS  PubMed  Google Scholar 

  45. Duseja A, Chawla YK. Obesity and NAFLD: the role of bacteria and microbiota. Clin Liver Dis. 2014;18(1):59–71.

    Article  PubMed  Google Scholar 

  46. Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC, Chan HL. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol. 2013;12(2):256–62.

    Article  CAS  PubMed  Google Scholar 

  47. Song Y, Manson JE, Buring JE, Liu S. A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women. Diabetes Care. 2004;27:2108–15.

    Article  CAS  PubMed  Google Scholar 

  48. Da Silva HE, Arendt BM, Noureldin SA, Therapondos G, Guindi M, Allard JP. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls. J Acad Nutr Diet. 2014;114:1181–94.

    Article  PubMed  Google Scholar 

  49. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, Oren R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007;47:711–7.

    Article  CAS  PubMed  Google Scholar 

  50. Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, Jalali P, Kandasamy T, Prayitno N, Sherman M, Guindi M, Ma D, Heathcote JE. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol. 2008;48:300–7.

    Article  CAS  PubMed  Google Scholar 

  51. Park S, Choi Y, Um SJ, Yoon SK, Park T. Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. J Hepatol. 2011;54:984–93.

    Article  CAS  PubMed  Google Scholar 

  52. Ronis MJ, Baumgardner JN, Marecki JC, Hennings L, Wu X, Shankar K, Cleves MA, Gomez-Acevedo H, Badger TM. Dietary fat source alters hepatic gene expression profile and determines the type of liver pathology in rats overfed via total enteral nutrition. Physiol Genomics. 2012;44:073–1089.

    Article  CAS  Google Scholar 

  53. Jurado-Ruiz E, Varela LM, Luque A, Berná E, Cahuana G, Martinez-Force E, Gallego-Durán R, Soria B, Roos B, Romero Gómez M, Martín F. An extra virgin olive oil-rich diet intervention ameliorates the non-alcoholic steatohepatitis induced by a high-fat “Western type” diet in mice. Mol Nutr Food Res. 2017;61(3).

    Google Scholar 

  54. Jin R, Welsh JA, Le NA, Holzberg J, Sharma P, Martin DR, Vos MB. Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients. 2014;6:3187–201.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Barrera F, George J. The role of diet and nutritional intervention for the management of patients with NAFLD. Clin Liver Dis. 2014;18:91–112.

    Article  PubMed  Google Scholar 

  56. Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009;65:331–41.

    Article  PubMed  Google Scholar 

  57. Schäfer S, Kantartzis K, Machann J, Venter C, Niess A, Schick F, Machicao F, Häring HU, Fritsche A, Stefan N. Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest. 2007;37:535–43.

    Article  PubMed  Google Scholar 

  58. Yki-Järvinen H. Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance. Nutrients. 2015;7:9127–913.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. Aller R, de Luis DA, Izaola O, de la Fuente B, Bachiller R. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease. Eur Rev Med Pharmacol Sci. 2014;18(7):1041–7.

    CAS  PubMed  Google Scholar 

  60. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 2007;86(2):285–300.

    Article  CAS  PubMed  Google Scholar 

  61. Razavi Zade M, Telkabadi MH, Bahmani F, Salehi B, Farshbaf S, Asemi Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. Liver Int. 2016;36(4):563–71.

    Article  CAS  PubMed  Google Scholar 

  62. de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R. Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients. Nutricion Hospitalaria. 2010;25(5):730–5.

    PubMed  Google Scholar 

  63. Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138–43.

    Article  CAS  PubMed  Google Scholar 

  64. Abenavoli L, Milic N, Peta V, Alfieri F, De Lorenzo A, Bellentani S. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J Gastroenterol. 2014;20:16831–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Simpson SJ, Couteur DG, James DE, George J, Gunton JE, Solon-Biet SM, Raubenheimer D. The geometric framework for nutrition as a tool in precision medicine. Nutr Healthy Aging. 2017;4(3):217–26.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Solon-Biet SM, McMahon AC, Ballard JW, Ruohonen K, Wu LE, Cogger VC, Warren A, Huang X, Pichaud N, Melvin RG, Gokarn R, Khalil M, Turner N, Cooney GJ, Sinclair DA, Raubenheimer D, Le Couteur DG, Simpson SJ. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 2014;19(3):418–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Raubenheimer D, Simpson SJ. Nutritional ecology and human health. Annu Rev Nutr. 2016;36:603–26.

    Article  CAS  PubMed  Google Scholar 

  68. Simpson SJ, Raubenheimer D, Cogger VC, Macia L, Solon-Biet SM, Le Couteur DG, George J. The nutritional geometry of liver disease including non-alcoholic fatty liver disease. J Hepatol. 2018;68(2):316–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Digestive Diseases UCM and Ciberehd, Virgen del Rocío University Hospital, Institute of Biomedicina of Seville, University of Seville, Seville, Spain

    Yolanda Sánchez-Torrijos & Manuel Romero-Gómez

  2. CABIMER—Pablo Olavide University, Seville, Spain

    Leticia Álvarez-Amor & Franz Martín

  3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain

    Leticia Álvarez-Amor & Franz Martín

  4. Digestive Diseases, Hospital Clínico de Valladolid, University of Valladolid, Valladolid, Spain

    Rocío Aller

  5. Endocrinology Unit, Virgen del Rocío University Hospital, Seville, Spain

    Pedro Pablo García-Luna

Authors
  1. Yolanda Sánchez-Torrijos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leticia Álvarez-Amor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rocío Aller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pedro Pablo García-Luna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Franz Martín
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Manuel Romero-Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manuel Romero-Gómez .

Editor information

Editors and Affiliations

  1. Department of Medical Sciences, Division of Gastroentrology and Hepatology, University of Turin, Turin, Italy

    Elisabetta Bugianesi

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sánchez-Torrijos, Y., Álvarez-Amor, L., Aller, R., García-Luna, P.P., Martín, F., Romero-Gómez, M. (2020). Dietary Approach to NAFLD. In: Bugianesi, E. (eds) Non-Alcoholic Fatty Liver Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-95828-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95828-6_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95827-9

  • Online ISBN: 978-3-319-95828-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation